Location History:
- Park City, IL (US) (1980)
- Gurnee, IL (US) (1980)
- Lindenhurst, IL (US) (1996)
Company Filing History:
Years Active: 1980-1996
Title: **Wayne R Heitmann: Innovator in Pharmaceutical Chemistry**
Introduction
Wayne R Heitmann is a distinguished inventor based in Lindenhurst, IL, known for his contributions to pharmaceutical chemistry. With a total of three patents to his name, Heitmann has made significant advances in the preparation of key compounds used in various medical applications.
Latest Patents
One of his most notable recent patents is focused on the **Process and intermediate for the preparation of terazosin hydrochloride**. This innovative process involves reacting 4-amino-2-chloro-6,7-dimethoxy-quinazoline with N-(2-tetrahydrofuroyl)piperazine in an anhydrous polar organic solvent. This method effectively produces anhydrous 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride, which is then converted into its dihydrate form.
Another significant patent, titled **Process for making 4-aroyl-substituted phenoxyacetic acids**, highlights his work in synthesizing powerful uricosuric diuretics. This method showcases a one-pot reaction capable of yielding 2,3-Dichloro-4-(hydroxybenzoyl)phenoxyacetic acid and its analogs from loweralkyl 2,3-dichloro-4-(nitrobenzoyl)phenoxyacetate.
Career Highlights
Wayne R Heitmann is currently associated with Abbott Laboratories Corporation, a leading global healthcare company known for its innovative solutions and pharmaceuticals. His role there has facilitated his contributions to various research initiatives and has solidified his reputation in the industry.
Collaborations
Throughout his career, Heitmann has collaborated with colleagues such as Anthony Mannino and Rodger F Henry, contributing to numerous projects that have advanced the field of pharmaceutical sciences. Their teamwork exemplifies the collaborative spirit necessary for innovation in the complex world of drug development.
Conclusion
Wayne R Heitmann stands out as a prominent inventor in the pharmaceutical industry. His work on processes related to terazosin hydrochloride and uricosuric agents underlines his expertise and commitment to enhancing drug development. With a strong foundation in scientific research and collaborative endeavors, Heitmann continues to make impactful contributions in his field.